And breast cancer-related TINCR ubiquitin domain containing (TINCR) impaired the efficacy of immunotherapy via posttranslational modification of programmed cell death 1 ligand 1 (PDL1) [10]. This evidence concerns the gene TINCR and breast carcinoma.